GILD vs NBIX
Gilead Sciences, Inc. - Common Stock · Neurocrine Biosciences, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | GILD | NBIX |
|---|---|---|
| Price | $153.54 | $135.91 |
| Market Cap | $190.38B | $13.82B |
| P/E | 22.37 | 28.87 |
| P/B | 16.09 | 3.74 |
| P/S | 6.47 | 4.83 |
| ROE | 71.9% | 13.0% |
| Net Margin | 28.9% | 16.7% |
| Gross Margin | — | — |
| Revenue Growth | 2.4% | 21.4% |
| Dividend Yield | 2.06% | — |
| EPS | $6.86 | $4.71 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.